Centessa Pharmaceuticals (CNTA)
(Delayed Data from NSDQ)
$16.05 USD
+0.24 (1.52%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $16.60 +0.55 (3.43%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (82 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | -0.42 | -0.06 | 63.00 |
Year Ago Quarter Estimate | -0.40 | 0.10 | 52.25 |
Next Quarter Estimate | -0.47 | -2.06 | 66.00 |
Next Year Estimate | -1.71 | 10.96 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.01 | 17.50 | 15.67 |
Next Year | -1.79 | 16.60 | 11.34 |
Last 5 Years | NA | 5.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.62 |
Price/Book (MRQ) | 5.62 | 1.54 |
Price/Cash Flow (MRFY) | NA | 8.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -203.98% |
Return on Equity (TTM) | -63.08% | -81.98% |
Debt to Equity (MRQ) | NA | 0.64 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.